Gene · 7292
Papers4,164
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 4,164
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| TFAP2D drives neuroblastoma progression: a disulfidptosis-fatty acid metabolism-based molecular subtyping and prognostic model. | Transl Pediatr | 2026 | 41810181 | PubTator, text mining | PubMed |
| Differences in the expression profiles of m6A-related genes and the prognostic role in immunotherapy for lung adenocarcinoma patients. | Front Oncol | 2026 | 41809822 | PubTator, text mining | PubMed |
| A novel bispecific antibody targeting OX40L and TNFα for the targeted treatment of rheumatoid arthritis. | Antib Ther | 2026 | 41804384 | PubTator, text mining | PubMed |
| The role of OX40 in cancer immunotherapy: A comprehensive review from mechanisms to clinical applications. | Crit Rev Oncol Hematol | 2026 | 41796912 | PubTator, text mining | PubMed |
| The OX40/OX40L Axis Promotes Th2 Activity and Impairs Regulatory T Cell Function in Atopic Dermatitis. | Allergy | 2026 | 41793700 | PubTator, text mining | PubMed |
| PD-1 genetic fate mapping uncovers immune cell diversity mediating the efficacy of combined PD-1 blockade and chemotherapy. | Oncoimmunology | 2026 | 41787604 | PubTator, text mining | PubMed |
| Unraveling the role of LINC02657 in clear cell renal cell carcinoma: insights into tumor aggression, immune modulation, and treatment response. | Front Immunol | 2026 | 41782880 | PubTator, text mining | PubMed |
| Immune Network Construction and Prognostic Evaluation of Checkpoint Genes in Endometrial Cancer Using STRING, MCODE, and GEPIA2. | Cancer Diagn Progn | 2026 | 41778235 | PubTator, text mining | PubMed |
| Comparative GWAS using global and Indian Reference Panels reveals non-coding drivers of COVID-19 severity and mortality. | PLoS Negl Trop Dis | 2026 | 41774713 | PubTator, text mining | PubMed |
| Diagnosis and treatment of sarcoidosis based on immunological etiology and mechanisms. | Front Med (Lausanne) | 2026 | 41767532 | PubTator, text mining | PubMed |
| The safety and efficacy of in situ vaccine FOLactis for advanced hepatic malignancies. | Vaccine | 2026 | 41762827 | PubTator, text mining | PubMed |
| Combination of oncolytic viruses and immune checkpoint inhibitors for treatment of high-grade gliomas. | Front Neurol | 2026 | 41756179 | PubTator, text mining | PubMed |
| Multidimensional risk prediction model for infant atopic dermatitis: A prospective cohort study. | World Allergy Organ J | 2026 | 41755993 | PubTator, text mining | PubMed |
| HIV Membrane-Proximal External Region Scaffolded Immunogen as Killed Whole-Cell Genome-Reduced Vaccines. | Viruses | 2026 | 41754552 | PubTator, text mining | PubMed |
| Possible Crosstalk Between Small Intestinal Bacterial Overgrowth (SIBO) and Atopic Manifestations-A Short Overview. | Int J Mol Sci | 2026 | 41752000 | PubTator, text mining | PubMed |
| Integrated Weighted Gene Co-Expression Network and Single-Cell RNA Sequencing Analyses Reveal the Prognostic Significance of Hypoxia in Gastric Cancer. | Biomedicines | 2026 | 41751324 | PubTator, text mining | PubMed |
| The Gut Microbiota-Mast Cell Axis in Intestinal Homeostasis and Food Allergy Pathogenesis. | Biomolecules | 2026 | 41750324 | PubTator, text mining | PubMed |
| Increasing the Response of Mismatch Repair Proficient Rectal Cancer to Immunotherapy with Particle Radiation and DNA Damage Response Inhibitors-Preclinical Evidence. | Cancers (Basel) | 2026 | 41749935 | PubTator, text mining | PubMed |
| Proposition for a New Classification of Hypersensitivity Reactions - an Expanded Nomenclature. | Clin Rev Allergy Immunol | 2026 | 41746569 | PubTator, text mining | PubMed |
| Cuproptosis-related gene signatures define immune subtypes and predict prognosis in gastric cancer. | Front Mol Biosci | 2026 | 41737832 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7292/papers?page=3